Medication info
Jadiflozin 25mg (Empagliflozin)

Jadiflozin 25mg (Empagliflozin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›25mg / 1 tablet
Manufacturer / importer
Youngpoong Pharmaceutical Co., Ltd.
Appearance
Light yellow, biconvex, oval film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202102103 · Approved 2021.03.05 · Insurance code 661905660

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes
Who takes it
Adults
Adult dose
The recommended dose of this medication is 10 mg once daily, either as monotherapy or as add-on combination therapy with other blood glucose-lowering agents, such as insulin. If 10 mg of this medication is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medication is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, Section 3. Adverse Reactions). This medication may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Treatment with this medication should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medication well but have a persistently estimated glomerular filtration rate below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose of this medication should be adjusted to or maintained at 10 mg once daily. This medication should be discontinued if the estimated glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medication in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medication is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older. Initiation of treatment with this medication is not recommended in patients aged 85 years and older, as clinical experience is limited (see Precautions for Use, Section 4. General Precautions)

Ingredients

Manufacturer
Youngpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes

  • Difficulty in blood glucose control
  • inability to control blood glucose
  • cardiovascular disease
View approved original text

This medication is primarily used to improve blood glucose control in adult patients with type 2 diabetes. It can be administered alone in conjunction with dietary and exercise therapy, or in combination with other antidiabetic medications such as metformin, pioglitazone, sulfonylureas, insulin, or DPP-4 inhibitors, if blood glucose control is insufficient. It is particularly important for patients with type 2 diabetes who have cardiovascular disease to follow expert guidelines not only for blood glucose control but also for the risk of cardiovascular events. This combined treatment approach effectively aids in managing diabetes and improving blood glucose levels.

How to take

Adult dose

The recommended dose of this medication is 10 mg once daily, either as monotherapy or as add-on combination therapy with other blood glucose-lowering agents, such as insulin. If 10 mg of this medication is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medication is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, Section 3. Adverse Reactions). This medication may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations • Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Treatment with this medication should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medication well but have a persistently estimated glomerular filtration rate below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose of this medication should be adjusted to or maintained at 10 mg once daily. This medication should be discontinued if the estimated glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medication in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medication is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older. Initiation of treatment with this medication is not recommended in patients aged 85 years and older, as clinical experience is limited (see Precautions for Use, Section 4. General Precautions)

Precautions

This medication should not be used in patients who are allergic to the active ingredient. This medication may be dangerous if administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with severely impaired kidney function, end-stage renal disease, or those on dialysis should not use this medication. This medication contains lactose and should not be administered to patients with genetic problems such as lactose intolerance, galactose intolerance, lactose deficiency, or glucose-galactose malabsorption. Patients with reduced kidney function require dose adjustment when taking this medication, and it should be discontinued if kidney function falls below a certain level. The use of this medication is not recommended in patients with severe heart failure and should be administered carefully in mild cases. If used in combination with insulin or insulin secretagogues, there may be an increased risk of hypoglycemia, so dose adjustments of these medications may be necessary. While taking this medication, patients may experience side effects such as hypoglycemia, genital infections, urinary tract infections, increased urination, and reduced fluid volume, so caution is advised. Severe metabolic abnormalities such as ketoacidosis may occur, so if symptoms like vomiting, abdominal pain, or difficulty breathing arise, immediate consultation with medical personnel is required. Elderly patients or those at risk of fluid volume depletion should be cautious of dehydration and hypotension, and fluid status should be checked regularly. This medication can cause serious urinary infections such as urosepsis and pyelonephritis, so prompt treatment is necessary if infection symptoms arise. Pregnant women are advised not to take this medication, and it should be avoided during breastfeeding as well. The safety and efficacy of this medication in children under 18 years of age have not been established, so it should not be used in this population. Although no specific toxic symptoms have been reported with overdose, appropriate treatment is necessary depending on the clinical condition. This medication may cause mild effects when driving or operating machinery, so caution should be exercised, especially if there is a risk of hypoglycemia. Additionally, diabetic patients should pay attention to foot care and regularly check their feet to reduce the risk of limb amputation. If pain, swelling, or redness appears around the perineum, immediate notification to medical personnel and appropriate treatment should be sought.

Side effects

  • Hypoglycemia
  • vulvovaginitis
  • balanitis
  • other genital infections
  • increased urination
  • urinary tract infection
  • decreased fluid volume
  • dehydration
  • hypotension
  • decreased blood volume
Show 216 more
  • orthostatic hypotension
  • syncope
  • increased serum creatinine
  • decreased glomerular filtration rate
  • ketoacidosis
  • urosepsis
  • pyelonephritis
  • rash
  • urticaria
  • angioedema
  • perineal necrosis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • colorectal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureterolithiasis
  • acute kidney injury
  • cervicitis
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • low back pain
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • exudative retinal detachment
  • limb injury
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • benign neoplasm of the ampulla of Vater
  • benign ovarian tumor
  • bladder cancer
  • gastric cancer
  • pancreatic carcinoma
  • rectal cancer
  • thyroid cancer
  • uterine leiomyoma
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • epigastric pain
  • dental caries
  • erosive gastritis
  • abdominal discomfort
  • dry mouth
  • gastroesophageal reflux disease
  • abdominal distention
  • hemorrhoidal bleeding
  • chronic gastritis
  • enteritis
  • meteorism
  • gastric polyp
  • gingival swelling
  • hematochezia
  • hemorrhoids
  • pancreatic cyst
  • rectal pain
  • toothache
  • upper respiratory tract infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • tinea capitis
  • dental abscess
  • nasopharyngitis
  • positional dizziness
  • sensory impairment
  • perceptual disturbances
  • amnesia
  • diabetic neuropathy
  • facial paralysis
  • memory disturbances
  • neuralgia
  • Parkinsonism
  • polyneuropathy
  • sensory deficits
  • drowsiness
  • fatigue
  • peripheral edema
  • facial edema
  • peripheral swelling
  • chills
  • strange sensations
  • edema
  • pain
  • tenderness at the puncture site
  • weight gain
  • electrocardiogram abnormalities
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urinary red blood cells
  • hematuria
  • hypertonic bladder
  • renal mass
  • urinary retention
  • urinary pain
  • abnormal urination
  • benign prostatic hyperplasia
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • scrotal pain
  • sexual dysfunction
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • subsequent syndrome
  • hyperlipidemia
  • vitamin D deficiency
  • dermal cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal canal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • eye discomfort
  • eye congestion
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • cough
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • falls
  • hand fracture
  • iliotibial band syndrome
  • open globe injury
  • pelvic fracture
  • palpitations
  • tachycardia
  • arteriosclerosis
  • diabetic vascular disorders
  • peripheral arterial occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • insomnia
  • acute cholecystitis
  • hepatitis
  • otalgia
  • positional vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • constipation
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • diabetic retinopathy
  • dry eyes
  • dyspnea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from air and moisture. It is best to store it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Light yellow, biconvex, oval film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.